Background--Atherosclerosis progression during aging culminates in the development of vulnerable plaques, which may increase the risk of cardiovascular events. Increased generation and/or decreased scavenging of reactive oxygen species in the vascular wall are major contributors to atherogenesis. We previously showed that superoxide dismutase 2 deficiency increased vascular oxidative stress and reduced aortic compliance in aged wild-type mice and that young Apoe À/À /Sod2 +/À had increased mitochondrial DNA damage and atherosclerosis versus young Apoe À/À mice. Here we investigated the effects of superoxide dismutase 2 deficiency on atherosclerosis progression and plaque morphology in middle-aged Apoe À/À mice.
C ardiovascular diseases, including atherosclerosis and its sequelae, are leading causes of death in the Western world. Together, ischemic heart disease and stroke were responsible for over 10 million deaths globally in 2013 1 and for 1 in 3 deaths in the United States. 2 Atherosclerotic plaque temporal changes are characterized by progression from pathological intimal thickening to fibroatheroma to thin-cap fibroatheroma and, ultimately, to plaque rupture and thrombus formation. 3 The culprit plaque, often described as unstable or vulnerable plaque, is characterized by a large necrotic core and a thin fibrous cap infiltrated with macrophages and lymphocytes and with the absence of or a few smooth muscle cells (SMC). 4, 5 The pathophysiology of vulnerable atherosclerotic plaque has been extensively studied; however, the exact molecular mechanisms of plaque progression and the triggers of plaque rupture remain largely unknown.
Aging is one of the major nonmodifiable risk factors for atherosclerosis and related vascular complications. The prevalence of coronary heart disease is 10-fold greater in the 40-to 59-year age group than in the 20-to 39-year age group, increasing linearly in the older population. 2 Similarly, the prevalence of cardiovascular disease is 4-fold greater in the 40-to 59-year group versus the 20-to 39-year age group, increasing rapidly in the older population, albeit in a nonlinear fashion. Cardiovascular aging is associated with chronic vascular inflammation and dysfunction, extensive extracellular matrix remodeling, and fibrotic changes. 6, 7 At the cellular level, aging results in enhanced oxidative stress and macromolecular damage, increased cell proliferation, senescence, and apoptosis. Further, increased levels of reactive oxygen species (ROS) in the vascular wall were implicated as causative during all clinical stages of atherosclerosis. 8 Consistent with this, aging was associated with increased cellular and mitochondrial ROS (mtROS) in the vascular cells and augmented atherosclerotic lesions with enhanced macrophage infiltration in hypercholesterolemic mice. 9 Further, aging-associated mitochondrial oxidative stress (mtOS) resulted in mitochondrial DNA (mtDNA) damage, mitochondrial and vascular dysfunction, and atherosclerosis. 10, 11 The cellular redox balance in aging vasculature shifts toward decreased levels of antioxidant enzymes, including mitochondrial superoxide dismutase 2 (SOD2). 12 We previously showed that SOD2 deficiency in aging mice results in vascular SMC apoptosis and matrix remodeling, leading to increased vascular and cardiac dysfunction. 13 Additionally, middle-aged Apoe À/À mice fed a Western diet had increased mtROS levels, and treatment with MitoTEMPO, a mitochondrial antioxidant, decreased atherosclerosis and preserved vascular and cardiac function. 9 The current study investigated whether SOD2 deficiency in oxidative stress-and atherosclerosis-prone middle-aged Apoe À/À mice exacerbates atherosclerotic plaque burden and induces plaque instability, using young (4-month-old) and middle-aged (16- 
Methods Animals
All procedures were performed in compliance with protocols approved by the University of Michigan Institutional Animal Care and Use Committee in accordance with NIH guidelines. All mice were purchased from Jackson Laboratory (Bar Harbor, ME). Male wild-type, Sod2 +/À (B6.129S7-Sod2 tm1Leb /J), 
/Sod2
+/À mice were bred on the C57BL/6J background. Experimental mice were generated from breeding heterozygous mice, and genotypes were confirmed by polymerase chain reaction. Mice were housed in specific pathogen-free rooms in ventilated cages at 22°C with 12-hour light/dark cycles and free access to food and water. Animals (n=16 per group) were fed standard rodent chow for 1 (young) or 13 months (middleaged) and then switched to the Western diet (Harlan Teklad TD.88137; Envigo, Madison, WI) for 3 months. Mice were treated with MitoTEMPO (Sigma-Aldrich, St. Louis, MO) at 1500 lg/kg per day for 12 weeks as described previously. 9 Briefly, at 13 months of age mice were randomly assigned to a MitoTEMPO or a vehicle treatment group (n=12). Microosmotic pumps (ALZET 1004; Durect, Cupertino, CA) were implanted subcutaneously under 2% inhaled isoflurane/O 2 anesthesia. The pumps were replaced every 4 weeks. Mice were fed the Western diet for the duration of the experiment.
Vascular SMC Isolation, Culture, and siRNA Transfection
The SMC were isolated from aortas of 4-and 16-month old wild-type and Sod2 +/À mice as described before. 9 Aortas from 3 to 4 animals were pooled together as 1 isolate, and 2 to 3 different isolates were used in 3 to 4 independent experiments. Cells were grown in DMEM supplemented with 10% fetal bovine serum and an antibiotic-antimycotic in a 5%
Clinical Perspective
What Is New?
• Vascular mitochondrial oxidative stress increases with aging under hyperlipidemic conditions, resulting in enhanced atherosclerotic plaque inflammation, necrotic core and fibrous cap remodeling, and susceptibility to rupture.
• Selective targeting of mitochondrial reactive oxygen species with a superoxide dismutase mimetic attenuated features of atherosclerotic plaque instability in aging hypercholesterolemic mice.
What Are the Clinical Implications?
• Screening and monitoring of elderly coronary artery disease patients for mitochondrial oxidative stress markers such as mitochondrial DNA damage may help identify individuals with vulnerable plaques and increased risk of adverse cardiovascular events.
• Using mitochondria-targeted antioxidants as adjunct therapy to traditional coronary artery disease treatments may prevent atherosclerotic plaque destabilization and reduce atherosclerosis complications.
CO 2 incubator at 37°C. Cells were used between passages 3 and 10. Mouse Capn2 ON-TARGET plus SMARTpool siRNA (L-043027-00) and nontargeting siRNA control (D-001810-01) were purchased from Dharmacon (GE Healthcare, Pittsburgh, PA). Cells were transfected using p5RHH peptide-siRNA nanocomplexes as described before.
14 Briefly, nanocomplexes were prepared by mixing p5RHH peptide and siRNA oligo at 1:200 in Opti-MEM medium and incubating for 40 minutes at 37°C. Vascular SMC (VSMC) were grown in 6-well plates to 70% confluence, quiesced overnight in DMEM, incubated with nanocomplexes for 4 hours at 37°C, and then treated with tumor necrosis factor a plus interferon c (TNFa+IFNc) or vehicle for 16 hours. Efficiency of siRNA knockdown was confirmed by Western blot analysis.
Histology and Immunostaining
Mice were euthanized with inhaled isoflurane and perfused with phosphate-buffered saline through a cardiac puncture. Aortas were dissected, opened longitudinally, pinned on black wax, stained with oil red O and 0.1% toluidine blue, and imaged. Alternatively, aortas were fresh frozen in OCT compound (Sakura Finetek, Torrance, CA), and transverse serial sections were cut at 10-lm thickness every 100 lm through aortic arch and descending thoracic aorta. Frozen tissue sections were stained with oil red O, Verhoeff picrosirius red, or hematoxylin and eosin, imaged, and analyzed with NIH ImageJ 1.49 (Bethesda, MD). Immunohistochemistry and immunofluorescence were performed as described previously. 9 Consecutive adjacent sections from ascending aorta and aortic arch were stained for various markers, and representative images from several mice (n=6-8) were selected. 0 ,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). Fluorescence or bright-field images were acquired with a Nikon Microphot-FX microscope at the same exposure, gain, and offset. Fluorescent images for each color channel were merged using Adobe Photoshop CC. Fluorescence intensity was determined by integrated density (mean gray value per area) measured with NIH ImageJ in the defined region of interest (ROI) and adjusted to the number of cell nuclei within the ROI. In the images stained for calpain-2 and cleaved caspase-3 ROI included the fibrocellular cap at the plaque shoulder region and adjacent media. In the images stained for MMP2 ROI included fibrous cap, neointima, and adjacent media at the plaque shoulder region. In the images of the aortic section stained for 8-OHdG and counterstained with DAPI, nuclei positive for 8-OHdG were pseudocolored green and counted as a fraction of total nuclei number per section. In the images of the aortic sections costained for 8-OHdG, ATP5G2, and DAPI, the cells with nonnuclear 8-OHdG and mitochondrial colocalization were counted as a fraction of total cell number per section. 15 
Western Blot Analysis
Western blot analysis was performed as described. 9 Primary antibodies used were against calpain-1 (Thermo Scientific), calpain-2 large subunit, cleaved caspase-3 (Asp175), MMP2, phospho-H2AX (Cell Signaling Technology), and b-actin (Sigma-Aldrich). With use of appropriate secondary horseradish peroxidase-conjugated antibody, protein bands were visualized with chemiluminescent reagent on x-ray film.
Densitometric quantification was performed using NIH ImageJ 1.49.
ROS Detection
Aortic wall ROS were detected with DHE and MitoSOX Red fluorescence as described previously. 9 Fluorescence images were taken using a Nikon Microphot-FX microscope with 510 nm excitation/580 nm emission filters. Grayscale images were analyzed with NIH ImageJ 1.49 software to determine mean gray value per area of the plaque and adjacent media (integrated density). The cellular superoxide levels were determined with HPLC detection of 2-hydroxyethidium as described before. 9, 16 Briefly, after treatments VSMC were incubated with 50 lmol/L of DHE (Thermo Scientific), harvested in acetonitrile, and supernatants dried using Savant ISS 100 (Thermo Scientific). Samples were dissolved in PBS and analyzed with an Agilent 1100 HPLC system equipped with a Partisil 5 lm ODS3 25094.6 mm column (Phenomenex, Torrance, CA). Quantification was performed using the 2-hydroxyethidium standard (Noxygen Science Transfer & Diagnostics GmbH, Elzach, Germany).
TUNEL Assay
Transverse aortic sections were terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) stained using an In Situ Cell Death Detection Kit (Roche, Indianapolis, IN) following the manufacturer's protocol. Briefly, sections were fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100, and incubated with a mixture of terminal deoxynucleotidyl transferase and labeled nucleotides. Sections were mounted with Vectastain mounting medium for fluorescence with DAPI (Vector Laroratories, Burlingame, CA). Fluorescence images were acquired with a Nikon Microphot-FX microscope and analyzed using NIH ImageJ 1.49 software. In the analyzed images TUNEL-positive nuclei were pseudocolored green and counted as a fraction of total number of nuclei within the plaque.
In Situ Zymography
The MMP activity in the aortic wall was determined as described previously. 17 Briefly, fresh frozen aortic sections were incubated with 20 lg/mL of DQ gelatin conjugated to fluorescein (Thermo Scientific) for 30 minutes at 37°C. The enzymatic activity of metalloproteinase in situ results in accumulation of highly fluorescent peptides. Fluorescent images were acquired with a Nikon Microphot-FX microscope using 495 nm excitation/515 nm emission filters. Fluorescence intensity was determined using NIH ImageJ by measuring integrated density normalized to the number of cell nuclei within the defined ROI that included fibrous cap, neointima and adjacent media at the plaque shoulder region.
Mitochondrial Protein Carbonyl Content and Mitochondrial Function
Mitochondria were isolated from VSMC of 4-and 16-monthold wild-type and Sod2 +/À mice using the Mitochondria Isolation Kit for Cultured Cells (Thermo Scientific) and protein carbonyl concentration was measured using the Protein Carbonyl Assay Kit (Cayman Chemical Company, Ann Arbor, MI) according to the manufacturer's protocol. Mitochondrial complex I activity was determined by measuring the reduction of NADH-sensitive Epsilon dye at 450 nm using Complex I Enzyme Activity Microplate Assay Kit (Abcam) following the manufacturer's protocol. Mitochondrial complex III activity was determined in isolated mitochondria by measuring the reduction of cytochrome C at 550 nm with antimycin A-specific activity subtracted from the total activity to calculate complex III-specific activity, as described in. 9, 18 Plasma Sample Collection, Clinical Biochemistry Tests and Free 8-Isoprostane Levels Plasma samples were collected from anesthetized mice through cardiac puncture as described previously. 19 Plasma lipid levels were measured using the AMS Lyasis 330 Clinical Chemistry System (AMS Diagnostics, Weston, FL). Plasma ALT, creatinine, and BUN were measured on an Automated Chemical Analyzer VT350 (Johnson & Johnson, New Brunswick, NJ). Plasma levels of free 8-isoprostane were determined with the EIA kit (Cayman Chemical) according to the manufacturer's protocol.
Statistical Analysis
All analyses were performed using JMP Pro 11.0.0 (SAS Institute, Cary, NC) or Prism 7 (GraphPad Software, La Jolla, CA). All data were tested for normality using the Shapiro-Wilk test. The data were transformed using square root, logarithm or a reciprocal transformation until the goodness-of-fit test was no longer reaching significance. ) to the levels similar to middle-aged Apoe À/À mice ( Figure 1C ).
Smaller but significant increases in mtROS levels were also observed in middle-aged Apoe À/À /Sod2 +/À compared to middle-aged Apoe À/À (25%) and young Apoe À/À /Sod2 +/À (22%) mice. As in total vascular ROS levels, mtROS levels were maximum in middle-aged Apoe À/À /Sod2 +/À compared to other groups, indicating how cellular ROS in general and mtROS in particular contribute to increased atherosclerotic burden in middle-aged Apoe À/À /Sod2 +/À mice.
Increased DNA damage was reported in human atherosclerotic plaque VSMC, promoting plaque instability. 21 To understand the role of increased oxidative stress on atherosclerotic plaque morphology in aging and hypercholesterolemia, we measured nuclear DNA damage by immunostaining aortic cross sections for 8-hydroxy-2 0 -deoxyguanosine (8-OHdG), an oxidative DNA damage marker. 9 A significant increase in 8-OHdG-positive nuclei was observed with age in the aortas of both Apoe À/À and Apoe À/À /Sod2 +/À mice (P<0.05 versus respective young mice; Figure 1D ), whereas that number was higher in the aortas of both young and middle-aged Apoe À/À /Sod2 +/À compared to age-matched Apoe À/À mice (P<0.001 and P<0.05, respectively). Two-way ANOVA showed a significant interaction between the effects of aging and genotype (P=0.0096), indicating that increased nuclear DNA damage with age and SOD2 deficiency increases atherosclerotic plaque burden and induces features of plaque instability. Because increased mtDNA damage was correlated with the plaque size in experimental and human atherosclerosis and considered a causal factor in atherogenesis, 11, 22 we also investigated mtDNA damage in young and middle-aged Apoe À/À /Sod2 +/À mice. Similar to nuclear DNA damage, mtDNA damage, as determined by colocalization of immunoreactive nonnuclear 8-OHdG and ATP synthase 5 subunit C2 (ATP5G2), a mitochondrial marker, increased with age in the aortas of both Apoe À/À and Apoe À/À /Sod2 +/À and in young and middle-aged Apoe À/À /Sod2 +/À compared to age-matched Apoe À/À mice ( Figure 1E ). MtDNA damage was prominent in VSMC of advanced atherosclerotic plaques and was primarily evident in the fibrous cap area at the plaque shoulder regions. SOD2 deficiency did not affect lipid metabolism ( Figure S1 ), further affirming the direct roles the role of mtOS and mtDNA damage in age-associated atherosclerosis in hypercholesterolemic settings. Figure 2D ).
Atherosclerotic Lesions in Middle-Aged Apoe
Fourth, fibrous cap thickness at the plaque shoulder region, the common site of fibrous cap disruption and plaque rupture, 3 was similar in aortas of young Apoe À/À and Apoe À/À /Sod2 +/À mice but increased significantly in middle-aged Apoe À/À mice (P<0.001; Figure 2E Figure 2F ). Similarly, the SMC content increased significantly with age in plaques of Apoe À/À mice (P<0.001).
However, atherosclerotic plaques from middle-aged Apoe Figure 2 . Atherosclerotic plaque morphology in young and middle-aged Apoe À/À and Apoe À/À /Sod2 +/À mice. A, Representative images of aortic transverse sections were stained for immunoreactive CD11b and inflammatory cell infiltration determined by quantification of the CD11b-positive staining area (meanAESEM, n=8). B and C, Representative images of aortic transverse sections stained for immunoreactive VCAM1 (B) or CD3c (C) (red), smooth muscle a-actin (green), and DAPI (blue) and quantification of VCAM1 (B) or CD3c (C) expression represented as fluorescence integrated density (IntDen) per number of cells (meanAESEM, n=8). D, Necrotic core size was determined by measuring the acellular fraction of the total plaque area (meanAESEM, n=9). E, Representative images of transverse aortic sections stained with Verhoeff picrosirius red and quantification of the fibrous cap thickness measured at the atherosclerotic plaque shoulder region (meanAESEM, n=8). F, Representative images of transverse sections stained for smooth muscle a-actin. Atherosclerotic plaque smooth muscle content was quantified by measuring the a-actin-positive staining area (meanAESEM, n=8). G, Representative images of aortic sections stained for TER119 (green), smooth muscle a-actin (red) and DAPI (blue) and quantification of number of transverse aortic sections positive for intraplaque hemorrhage (meanAESEM, n=9). H, Representative images of transverse aortic sections from middle-aged Apoe À/À and Apoe À/À /Sod2 +/À mice stained with Verhoeff picrosirius red showing interruption of fibrous cap (arrowhead). A indicates atheroma; L, lumen; M, media. Scale is 100 lm. *P<0.05; **P<0.01; ***P<0.001; NS, not significant; SEM, standard error of the mean.
Increase in mtROS With Aging in VSMC of Sod2

+/À Mice Induces Mitochondrial Dysfunction
To understand the mechanisms that regulate VSMC function in the progression of advanced atherosclerotic lesions during aging and to avoid the confounding effects of hypercholesterolemia, we examined mitochondrial function in VSMC isolated from young and middle-aged wild-type and Sod2 +/À mice. Because atherosclerotic plaque SMC are exposed to IFNc secreted by T-cells and TNFa from activated macrophages in the lesions, 29 we first determined the combined effect of these 2 cytokines on VSMC ROS levels by measuring 2-hydroxyethidium, a superoxide-specific product of hydroethidine, by HPLC analysis. The TNFa and IFNc-induced superoxide levels were significantly higher in the cells from both middle-aged wild-type and Sod2 +/À mice compared to their respective young controls ( Figure 3A ). In addition, SOD2 deficiency significantly enhanced cytokine-induced superoxide levels in VSMC from middle-aged wild-type mice. To determine whether the cytokines exert an effect primarily on mtROS levels, VSMC were treated with the cytokines in the presence and absence of MitoTEMPO. 9 MitoTEMPO pretreatment decreased cellular ROS levels to near-basal levels in all the groups, indicating that the observed increases in superoxide levels in response to various vasoactive agonists in aortic VSMC were of mitochondrial origin. However, Mito-TEMPO treatment did not decrease ROS to the basal levels of young mice VSMC, suggesting that extramitochondrial sources of cellular superoxide such as NADPH oxidases, lipoxygenases, and monoamine oxidase may contribute to aging-associated oxidative stress.
The current data showing a significant increase in carbonylation of mitochondrial proteins with age in VSMC from Sod2 +/À mice compared to wild-type ( Figure 3B ) are consistent with our prior results, which showed the association of increased mtROS levels with mitochondrial protein oxidative modification during aging. 9 Reflecting the increased protein carbonylation, activities of mitochondrial complex I and complex III were significantly lower in VSMC from both middle-aged wild-type and Sod2 +/À mice compared with their respective young controls; the SOD2 deficiency had an even greater inhibitory effect on age-associated decline in complex I and III activities in VSMC (P<0.05 versus wild-type; Figure 3C and 3D). Together, these data showed that the impaired antioxidant defense system further exacerbates the adverse effects of aging on mitochondrial oxidative burden and function in the aortic vascular cells.
Aging-Associated Mitochondrial Dysfunction
Induces Activation of Calpain-2 and MMP2 and DNA Damage in VSMC From Sod2 +/À Mice
Calpains are calcium-sensitive cysteine proteases that regulate inflammation, induce apoptosis, activate MMP2, and facilitate fibrotic changes in aortic wall in aging and atherosclerosis. 30, 31 To determine whether SOD2 deficiency and inflammatory cytokines affect calpain expression during aging, we measured calpain-1 and calpain-2 expression in VSMC from young and middle-aged wild-type and Sod2
+/À mice at basal levels and in response to TNFa+IFNc treatment. Calpain-1 expression was 3.5-fold higher in VSMC from both middle-aged wild-type and Sod2 +/À mice compared with their respective controls ( Figure 4A ). However, TNFa+IFNc treatment had no significant effect on calpain-1 expression in VSMC from both young and middle-aged mice. Basal calpain-2 expression was higher in VSMC from young Sod2 +/À mice versus wild-type mice. Its expression increased with age in cells from both groups but was significantly higher in the VSMC from middle-aged Sod2 +/À than in cells from middleaged wild-type mice ( Figure 4A ). TNFa+IFNc treatment caused a robust increase of calpain-2 protein levels in VSMC from middle-aged versus young Sod2 +/À mice but had no effect in cells from either young or middle-aged wild-type mice, suggesting that increased mitochondrial oxidative stress in aging selectively upregulates vascular calpain-2 expression ( Figure 4A ). To determine whether increased calpain-2 expression regulates VSMC apoptosis, we transfected VSMC with nontargeting siRNA:p5RHH or Capn2 siRNA:p5RHH nanocomplexes 14 and measured cleaved caspase-3 expression by Western analysis. Capn2 siRNA transfection selectively and significantly decreased basal calpain-2 protein levels in VSMC from middle-aged wild-type mice ( Figure S2 ) and TNFa+IFNc-induced calpain-2 levels in VSMC from both young and middle-aged wild-type and Sod2
+/
À mice compared to nontargeting siRNA ( Figure 4B ). Cleaved caspase-3 protein levels, which increased with age in both the cell types but significantly in VSMC from Sod2 +/À mice, were attenuated with Capn2 siRNA transfection ( Figure 4B ). In contrast, Capn2 siRNA transfection had no effect on TNFa+IFNc-induced cleaved caspase-3 levels in wild-type cells. Together, these data show that impaired antioxidant defense in aging activates signaling pathways that affect VSMC viability in the vascular wall. Basal MMP2 protein levels were significantly higher in both young and middle-aged Sod2 +/À VSMC compared to the wildtype cells; aging further increasing the protein levels in Sod2 +/À cells ( Figure 4C ). TNFa+IFNc treatment had no significant effect on MMP2 protein content in young and middle-aged wild-type and young Sod2 +/À VSMC. However, the MMP2 protein content was increased 2.6-fold in middleaged Sod2 +/À VSMC treated with TNFa+IFNc. Pretreatment of cells with calpain inhibitor PD150606 significantly decreased basal as well as TNFa+IFNc-induced MMP2 levels in both wild-type and Sod2 +/À VSMC ( Figure 4C ), suggesting that calpains are major regulators of MMP2 expression in VSMC. 31, 32 Because calpains regulate apoptosis 30 and DNA damage induces VSMC apoptosis, 33 we asked whether calpain induction regulates DNA damage in VSMC in aging under increased mtOS. Phosphorylation of histone H2AX (cH2AX), a marker of DNA double-strand breaks and DNA damage response, 21 was significantly increased with age in both wild-type and Sod2 +/À VSMC ( Figure 4C ). The
TNFa+IFNc treatment had no effect on cH2AX levels in both young and middle-aged wild-type and young Sod2 +/À VSMC but caused a significant increase (2.5-fold) in middle-aged Sod2 +/À VSMC. Pretreatment with PD150606 decreased cH2AX to near basal levels in middle-aged Sod2 +/À VSMC, providing evidence for the regulatory role of calpains in DNA damage in VSMC with increased mtOS during aging. Taken together, these data indicate that impaired SOD2 activity in aging might affect features of plaque stability by inducing mitochondrial dysfunction, matrix degradation, and VSMC apoptosis via increased mitochondrial protein oxidation and regulation of calpains, particularly calpain-2.
Atherosclerotic Plaque Shoulder Regions in Middle-Aged Apoe À/À /Sod2 +/À Mice Show Increased Calpain-2 and MMP2 Expression and Matrix Remodeling
It was previously reported that calpain-2 levels were significantly elevated in low-density lipoprotein receptor knockout (Ldlr À/À ) mice fed a high-cholesterol diet, and calpain inhibitors suppressed hypercholesterolemia-induced atherosclerosis and vascular inflammation. 34 Further, increased calpain and caspase-3 activities in isolated perfused hearts were significantly reduced in transgenic mice with cardiac-specific overexpression of SOD2 compared with hearts of wild-type mice. 35 To determine whether SOD2 , n=4) . B, Western blot analysis and densitometric quantification of calpain-2 and cleaved caspase-3 levels in VSMC treated with TNFa+IFNc and nontargeting control or Capn2 siRNA (meanAESEM, n=4). C, Western blot analysis and densitometric quantification of MMP2 and phospho-H2AX levels in VSMC treated with TNFa+ IFNc and 100 lmol/L PD150606 (meanAESEM, n=4). N represents a number of independent experiments. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; MMP indicates matrix metalloproteinase; mo, months; mtROS, mitochondrial reactive oxygen species; NS, not significant; SEM, standard error of the mean; VSMC, vascular smooth muscle cells.
Because calpains activate matrix-degrading metalloproteinases 31 and MMP2 activity increases in the arterial wall of middle-aged Sod2 +/À mice, 13 we analyzed MMP2 expression in mouse atherosclerotic plaque shoulder regions. The immunoreactive MMP2 expression was markedly increased in the fibrous cap as well as in total atherosclerotic plaque area in Apoe
MMP2 expression was significantly higher in middle-aged Apoe À/À /Sod2 +/À than in other mouse groups ( Figure 5C ).
Analysis of aortic sections stained with picrosirius red in polarized light showed evenly distributed collagen fibers in fibrous caps in 4-month-old Apoe À/À and Apoe À/À /Sod2 +/À mice. The collagen fibers were compactly arranged in atherosclerotic lesions of 16-month-old Apoe À/À , whereas they were disorganized in middle-aged Apoe À/À /Sod2 +/À mice ( Figure 5D ). In addition, the amount of fibrous cap collagen was significantly lower in atherosclerotic plaque fibrous cap of middle-aged Apoe À/À /Sod2 +/À mice. These results suggest that increased mtOS in aging under hypercholesterolemic conditions promotes features of atherosclerotic plaque vulnerability by inducing calpain-2 expression, increasing caspase-3 activation and MMP2-mediated SMC apoptosis and matrix degradation in the plaque shoulder regions, resulting in thin fibrous caps with low cellularity. Phenotypic transition of atherosclerotic plaque VSMC into macrophage-like cells enhances intraplaque inflammation and contributes to the plaque pathogenesis. 37 To assess whether aging and SOD2 deficiency contribute to SMC transdifferentiation, we analyzed mouse atherosclerotic plaques for cells coexpressing markers of both SMC (SMMHC and a-actin) and macrophage (CD68 and Mac3) lineages. , n=8) . B, Plasma levels of free 8-isoprostane (meanAESEM, n=8). C, Representative images and quantification of mouse aorta transverse sections stained with MitoSOX Red (meanAESEM, n=7). D, Representative images of aortic transverse sections stained for 8-OHdG (red), ATP5G2 (green), and DAPI (blue), and quantification of mitochondrial 8-OHdG-positive cells (meanAESEM, n=5). E, Atherosclerotic lesion necrotic core size presented as acellular fraction of the total plaque area (meanAESEM, n=7). F, Representative images of aortic transverse sections stained with Verhoeff picrosirius red and quantification of the fibrous cap thickness at the atherosclerotic plaque shoulder region (meanAESEM, n=7). G, Representative fluorescent microscopy images of aortic sections stained for TER119 (green), smooth muscle a-actin (red), and DAPI (blue) and quantification of the number of aortic sections showing intraplaque hemorrhage (n=7). A indicates atheroma; L, lumen; M, media; mo, months; mtOS, mitochondrial oxygen stress; NS, not significant; SEM, standard error of the mean. Scale is 100 lm. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. significant effects on lipid metabolism in middle-aged mice ( Figure S4A and S4B) . The treatment protocol had no toxic effects as determined by blood urea nitrogen ( Figure S4C ), creatinine ( Figure S4D ), alanine aminotransferase ( Figure S4E ) levels and kidney ( Figure S4F ) or liver morphological changes ( Figure S4G ). Atherosclerotic plaque mtROS levels were significantly decreased by MitoTEMPO in both middle-aged Apoe À/À and Apoe À/À /Sod2 +/À mice ( Figure 6C ). Additionally, MitoTEMPO significantly lowered the number of cells with 8-OHdG modification of mtDNA at the atherosclerotic plaque shoulder regions in both genotypes ( Figure 6D ). Analysis of aortic cross sections showed that necrotic core size, which was significantly increased in middle-aged Apoe 
Discussion
The present studies were designed to determine the interplay of impaired SOD2 activity, aging, and hypercholesterolemia on aortic atherosclerotic burden and on features of atherosclerotic plaque stability, which are associated with major adverse cardiovascular events. 40 We used middle-aged, 16-month-old mice, which are equivalent to %54-year-old humans, 41, 42 an age group with an exponential increase in the incidence of coronary heart disease and other cardiovascular diseases compared to a younger 20-to 39-year age group. 2 Lifelong deficiency of SOD2 activity increased atherosclerotic lesion volume and multiple features of plaque vulnerability in middleaged hyperlipidemic mice, including decreased plaque SMC content and fibrous cap thickness, increased VCAM1 expression and T-cell content, enlarged necrotic core size, and evidence of intraplaque hemorrhage and plaque fissures. The fibrous cap changes compatible with plaque fissure observed in these mice may also be a source of intraplaque hemorrhage. 43 In addition, our data provide evidence that in SOD2- activities. Taken together, these data suggest that increased mtOS and mitochondrial dysfunction under hyperlipidemic conditions in aging not only increases atherosclerotic plaque volume but also induces features of plaque instability, by accentuating DNA damage, perhaps via calpain-2-mediated mechanisms.
The current data showing extensive and advanced atherosclerosis in middle-aged hyperlipidemic SOD2 +/À mice are consistent with a previous report in which age-accelerated atherosclerosis in lipoprotein receptor knockout mice was attributed to an inability to mount a robust antioxidant response. 12 In this context, it is worth noting that the increased oxidized low-density lipoprotein levels under hyperlipidemic conditions, as seen in Apoe À/À mice, exacerbate mtROS production and induce cell apoptosis by stimulating SOD2 ubiquitination and degradation. 44 We and others demonstrated previously that cellular ROS levels are correlated with mtDNA damage, an early event in 37 Our results suggest that these processes are enhanced during aging and, in conjunction with increased mtOS, promote apoptosis and expansion of the necrotic core. The infiltration of erythrocytes in the lesions in middle-aged Apoe À/À /Sod2 +/ À mice on a high-fat diet is an indication of hemorrhage and evidence of intraplaque microvessels, which increase lesion vulnerability by facilitating continued extravasation of inflammatory cells into the lesions. 49 Increased blood pressure, another significant factor influencing plaque stability, increases peak circumferential stress at the plaque shoulder. 50 The elevated diastolic blood pressure and increased arterial stiffness in aged Sod2 +/À mice 13 might increase peak circumferential stress and, in combination with decreased cap thickness, may trigger plaque rapture at the shoulder region. 51 The data from our mechanistic studies on mouse aortic SMC, which are consistent with the in vivo findings, elucidate the underlying molecular mechanisms affecting atherosclerotic plaque burden and plaque vulnerability when multiple atherosclerotic risk factors including aging, increased oxidative stress, and hyperlipidemia converge on the vessel wall. The morphological features of advanced atherosclerotic plaques in middle-aged mice that we describe are relevant to age-dependent changes in human atherosclerosis. Kang et al reported that patients who are smokers and >65 years had more plaque burden and plaque instability (more necrotic core, thin-cap fibroatheromas, and positive remodeling) and more ruptures compared to patients who are nonsmokers and ≤65 years. 58, 59 In a similar report, Wendorff et al found a continuous increase in carotid plaque instability in men with age and a significant increase in plaque instability in the 65-to 69-year-old age group of patients in the probability analysis of age-associated quartiles related to the first quartile. 60 Statins have been established as the best pharmacotherapy for reduction of cardiovascular risk. In addition to lowering lipid levels, statins exert plaque stabilization effects by reducing intraplaque hemorrhage, plaque neovascularization, and endothelial dysfunction. 26, 49 However, a significant residual cardiovascular risk remains in patients on statin treatment. The success of immunomodulatory agents such as blocking antibodies against IFNc and CCL5 antagonists in inducing plaque stabilization in mouse models highlights the importance of inflammation in plaque destabilization. These reports are entirely consistent with the results of the present investigation showing that MitoTEMPO treatment improves atherosclerotic plaque stability in aging-associated atherosclerosis by attenuating mtOS and vascular inflammation. Also of potential relevance for cardiovascular risk reduction are reports that MitoTEMPO exerts salutary effects on angiotensin II-induced hypertension 61 and aging-associated decline in arterial compliance 9 in mouse models. More importantly, MitoTEMPO reduced hypertension and improved vasorelaxation in a mouse model of hyperacetylated and hypofunctional SOD2. 62 Targeting mtOS and dysfunction using mitochondria-targeted antioxidants, such as Mito-TEMPO, in combination with statins may represent an important opportunity for prevention of atherosclerotic plaque progression and instability during aging.
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